In one study, a polymeric nanoparticle encapsulating PTEN mRNA showed promise in both melanoma and prostate cancer models, where it was able to restore PTEN function in cancer cells, leading to the observed reduction in MDSCs and Tregs numbers (131). The gene discussed is PTEN; the disease is prostate carcinoma.